Matthew Klein

Vorstandsvorsitzender bei PTC THERAPEUTICS, INC.

Vermögen: 1 Mio $ am 30.04.2024

52 Jahre

Consumer Services

Health Technology

Commercial Services

Aktive Positionen von Matthew Klein

Unternehmen	Position	Beginn	Ende
CLEARPOINT NEURO, INC.	Direktor/Vorstandsmitglied	16.04.2020	-
CLEARPOINT NEURO, INC.	Independent Dir/Board Member	16.04.2020	-
PTC THERAPEUTICS, INC.	Direktor/Vorstandsmitglied	22.03.2023	-
	Vorstandsvorsitzender	22.03.2023	-
	Präsident	22.03.2023	-
	Geschäftsführer	07.01.2022	22.03.2023
	Corporate Officer/Principal	01.10.2019	07.01.2022
Stanford University	Corporate Officer/Principal	-	-

Unternehmen	Position	Beginn	Ende
BioElectron Technology Corp. BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA.	Direktor/Vorstandsmitglied	01.01.2018	01.01.2020
	Vorstandsvorsitzender	01.01.2018	01.01.2019
	Technik-/Wissenschafts-/F&E-Leiter	01.01.2012	01.01.2019
University of Washington University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA.	Corporate Officer/Principal	-	-
Edison Pharmaceuticals, Inc. Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edison Pharmaceuticals, Inc. developed drugs to treat mitochondrial diseases. It offers EPI-743 and EPI-A0001, an orally absorbed small molecules. The company was founded by Guy Miller in 2005 and was headquartered in Mountain View, CA.	Technik-/Wissenschafts-/F&E-Leiter	-	-

International

Vereinigte Staaten

Operativ

Corporate Officer/Principal	3
Director/Board Member	3
Chief Tech/Sci/R&D Officer	2

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
PTC THERAPEUTICS, INC.	Health Technology
CLEARPOINT NEURO, INC.	Health Technology

Private Unternehmen	2
Edison Pharmaceuticals, Inc. Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Edison Pharmaceuticals, Inc. developed drugs to treat mitochondrial diseases. It offers EPI-743 and EPI-A0001, an orally absorbed small molecules. The company was founded by Guy Miller in 2005 and was headquartered in Mountain View, CA.	Health Technology
BioElectron Technology Corp. BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services BioElectron Technology Corp. is a clinical-stage biotechnology company, which engages in the research and development of therapeutics for inherited mitochondrial disease. The company was founded in 2005 and is headquartered in Mountain View, CA.	Commercial Services